You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Funded Evidence-Informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

Regimens

88 Items
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative, Palliative
May 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative, Palliative
May 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative, Palliative
May 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative, Palliative
May 2019
Cancer Type: Hematologic, Leukemia - Acute Promyelocytic (APL)     
Intent: Palliative, Curative
Funding:
ODB - General Benefit
    mercaptopurine
ODB - General Benefit
    methotrexate - oral tablets
Exceptional Access Program
    tretinoin (ATRA)
May 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative, Palliative
May 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative, Palliative
May 2019
Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)     
Intent: Curative, Palliative
May 2019
Cancer Type: Genitourinary, Bladder / Urothelial     
Intent: Adjuvant, Palliative
Jun 2019
Cancer Type: Genitourinary, Testis     
Intent: Palliative
Jan 2018
Cancer Type: Gynecologic, Ovary     
Intent: Adjuvant, Palliative
Funding:
New Drug Funding Program
    Paclitaxel in Combination with Platinum - First Line - Advanced Ovarian Fallopian Tube or Primary Peritoneal Carcinoma
New Drug Funding Program
    Paclitaxel in Combination with Platinum - Recurrent - Advanced Ovarian Fallopian Tube or Primary Peritoneal Carcinoma
Aug 2017
Cancer Type: Gynecologic, Cervix     
Intent: Palliative
Apr 2016